AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NOXOPHARM LTD

0.084

-0.006-6.67%

Volume:51.07K

Turnover:4K

Market Cap:25.81M

PE:-4.42

High:0.085

Open:0.085

Low:0.084

Close:0.090

52wk High:0.110

52wk Low:0.051

Shares:307.24M

Float Shares:195.51M

Volume Ratio:0.71

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.019

EPS(LYR):-0.017

ROE:-343.56%

ROA:-66.18%

PB:-7.07

PE(LYR):-5.03

Loading ...

Overview Company News Filings

Noxopharm Ltd-pre-ind Meeting Request with US FDA

THOMSON REUTERS

Noxopharm Ltd-sofr Platform Versatility Shown Via Childbirth Mrff Grant

THOMSON REUTERS

BRIEF-Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness

Noxopharm Ltd - Sof-Skn Manufacturing Begins to Ensure Clinical Trial Readiness Highlights

THOMSON REUTERS

BUZZ-Australia's Noxopharm rises as novel cancer therapy shows potential

Noxopharm Ltd - New Data Confirms Cancer-Fighting Potential

THOMSON REUTERS

Noxopharm Ltd - Data Showing Sofra™ Technology Platform Will Be Leveraged to Fight Cancer

THOMSON REUTERS

Noxopharm Ltd-New Company Secretary Appointed

THOMSON REUTERS

Noxopharm Ltd-Innovative Collaboration Further Expands Sofra Platform

THOMSON REUTERS

BRIEF-Noxopharm Appoints Dr Olivier Laczka As New CEO

Noxopharm Ltd-Noxopharm Appoints DR Olivier Laczka as New CEO

THOMSON REUTERS

BRIEF-Noxopharm Ltd Announces Resignation Of Chief Executive Officer

Noxopharm Ltd - Announces Resignation of CEO and Md DR Gisela Mautner

THOMSON REUTERS

Noxopharm Ltd-Resignation of Chief Executive Officer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/NOX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NOX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","market":"AU","secType":"STK","nameCN":"NOXOPHARM LTD","latestPrice":0.084,"timestamp":1787897520000,"preClose":0.09,"halted":0,"volume":51074,"delay":0,"changeRate":-0.06666666666666657,"nameEN":"NOXOPHARM LTD","floatShares":195506720,"shares":307237950,"eps":-0.019,"marketStatus":"Not Yet Opened","change":-0.006,"latestTime":"08-28 16:12:00 AEST","open":0.085,"high":0.085,"low":0.084,"amount":4293,"amplitude":0.011111,"askPrice":0.09,"askSize":778,"bidPrice":0.083,"bidSize":25000,"shortable":3,"etf":0,"ttmEps":-0.019,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788134400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.09,"openAndCloseTimeList":[[1787875200000,1787896800000]],"volumeRatio":0.7074745135873357,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NOX.AU","preClose":0.092,"auctionPrice":0.09,"auctionVolume":776,"auction":3,"marketStatus":"盘后竞价","timestamp":1787810400547}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","floatShares":195506720,"roa":"-66.18%","roe":"-343.56%","lyrEps":-0.016712,"volumeRatio":0.7074745135873357,"shares":307237950,"dividePrice":0,"high":0.085,"amplitude":0.011111,"preClose":0.09,"low":0.084,"week52Low":0.051,"pbRate":"-7.07","psRate":"17.81","week52High":0.11,"institutionHeld":0,"latestPrice":0.084,"committee":0.939638,"eps":-0.019,"divideRate":0,"volume":51074,"delay":0,"ttmEps":-0.019,"open":0.085,"prevYearClose":0.093,"prevWeekClose":0.084,"prevMonthClose":0.082,"prevQuarterClose":0.087,"fiveDayClose":0.094,"twentyDayClose":0.082,"sixtyDayClose":0.078,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NOX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NOX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NOX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649167273","title":"Noxopharm Ltd-pre-ind Meeting Request with US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2649167273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649167273?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:34","pubTimestamp":1783380884,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUE9YSG0Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","NOX.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648524672","title":"Noxopharm Ltd-sofr Platform Versatility Shown Via Childbirth Mrff Grant","url":"https://stock-news.laohu8.com/highlight/detail?id=2648524672","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648524672?lang=en_us&edition=fundamental","pubTime":"2026-07-02 06:15","pubTimestamp":1782944152,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nTUE5KVLW6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","NOX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642845350","title":"BRIEF-Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2642845350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642845350?lang=en_us&edition=fundamental","pubTime":"2026-06-09 09:22","pubTimestamp":1780968176,"startTime":"0","endTime":"0","summary":"BRIEF-Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial ReadinessJune 9 (Reuters) - Noxopharm Ltd NOX.AX:SOF-SKN MANUFACTURING BEGINS TO ENSURE CLINICAL TRIAL READINESS Further company coverage: NOX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42G13S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NOX.AU","BK7501","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642243207","title":"Noxopharm Ltd - Sof-Skn Manufacturing Begins to Ensure Clinical Trial Readiness Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2642243207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642243207?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:30","pubTimestamp":1780957848,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nFWN42G13S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","BK7501","NOX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638307567","title":"BUZZ-Australia's Noxopharm rises as novel cancer therapy shows potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2638307567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638307567?lang=en_us&edition=fundamental","pubTime":"2026-05-26 11:39","pubTimestamp":1779766765,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Noxopharm rises as novel cancer therapy shows potential** Shares of Noxopharm NOX.AX rise as much as 58.3% to A$0.095, their biggest intraday pct gain since July 16, 2025** The biotech firm announces new data that reflects how its Sofra technology platform will be leveraged to fight cancer** Sofra focuses on the creation of a novel class of drugs targeting inflammatory and autoimmune diseases as well as enhancing RNA therapeutics and vaccines** Says data supports a new and different approach to addressing significant unmet needs in cancer treatment, paving the way for a potentially highly disruptive new treatment modality** More than 1.8 million shares change hands, 14.2 times the 30-day average** Stock down 9.7% YTD, including the day's moves  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nL4N42306J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","NOX.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638550066","title":"Noxopharm Ltd - New Data Confirms Cancer-Fighting Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2638550066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638550066?lang=en_us&edition=fundamental","pubTime":"2026-05-26 06:21","pubTimestamp":1779747684,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nFWN4220E7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","NOX.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638550065","title":"Noxopharm Ltd - Data Showing Sofra™ Technology Platform Will Be Leveraged to Fight Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2638550065","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638550065?lang=en_us&edition=fundamental","pubTime":"2026-05-26 06:21","pubTimestamp":1779747684,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nFWN4220E7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","NOX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631277035","title":"Noxopharm Ltd-New Company Secretary Appointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2631277035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631277035?lang=en_us&edition=fundamental","pubTime":"2026-04-30 06:19","pubTimestamp":1777501147,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUE9WQYZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","NOX.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630433143","title":"Noxopharm Ltd-Innovative Collaboration Further Expands Sofra Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2630433143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630433143?lang=en_us&edition=fundamental","pubTime":"2026-04-27 06:21","pubTimestamp":1777242111,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nTUE6X2JC5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","NOX.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627479669","title":"BRIEF-Noxopharm Appoints Dr Olivier Laczka As New CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2627479669","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627479669?lang=en_us&edition=fundamental","pubTime":"2026-04-15 09:51","pubTimestamp":1776217913,"startTime":"0","endTime":"0","summary":"BRIEF-Noxopharm Appoints Dr Olivier Laczka As New CEOApril 15 (Reuters) - Noxopharm Ltd NOX.AX:NOXOPHARM APPOINTS DR OLIVIER LACZKA AS NEW CEOFurther company coverage: NOX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUE3XSWDC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","NOX.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627769420","title":"Noxopharm Ltd-Noxopharm Appoints DR Olivier Laczka as New CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2627769420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627769420?lang=en_us&edition=fundamental","pubTime":"2026-04-15 07:27","pubTimestamp":1776209229,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUE3XSWDC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","NOX.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627498879","title":"BRIEF-Noxopharm Ltd Announces Resignation Of Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627498879","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627498879?lang=en_us&edition=fundamental","pubTime":"2026-04-14 09:38","pubTimestamp":1776130731,"startTime":"0","endTime":"0","summary":"BRIEF-Noxopharm Ltd Announces Resignation Of Chief Executive OfficerApril 14 (Reuters) - Noxopharm Ltd NOX.AX:NOXOPHARM LTD-RESIGNATION OF CHIEF EXECUTIVE OFFICERNOXOPHARM LTD - ANNOUNCES RESIGNATION OF CEO AND MD DR GISELA MAUTNERSource text: ID:nASX5NR8XlFurther company coverage: NOX.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUE68PQY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NOX.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627464149","title":"Noxopharm Ltd - Announces Resignation of CEO and Md DR Gisela Mautner","url":"https://stock-news.laohu8.com/highlight/detail?id=2627464149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627464149?lang=en_us&edition=fundamental","pubTime":"2026-04-14 07:55","pubTimestamp":1776124536,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUE68PQY3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NOX.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627464142","title":"Noxopharm Ltd-Resignation of Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627464142","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627464142?lang=en_us&edition=fundamental","pubTime":"2026-04-14 07:55","pubTimestamp":1776124536,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUE68PQY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","NOX.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}